Literature DB >> 16884976

Myocardial damage prevented by volatile anesthetics: a multicenter randomized controlled study.

Fabio Guarracino1, Giovanni Landoni, Luigi Tritapepe, Francesca Pompei, Albino Leoni, Giacomo Aletti, Anna Mara Scandroglio, Daniele Maselli, Monica De Luca, Chiara Marchetti, Giuseppe Crescenzi, Alberto Zangrillo.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the effects of volatile anesthesia versus total intravenous anesthesia on cardiac troponin release in off-pump coronary artery bypass grafting (OPCAB).
DESIGN: The authors performed a multicenter randomized controlled study to compare cardiac troponin release in patients receiving either volatile anesthetics or total intravenous anesthesia for cardiac surgery on the beating heart, which is an excellent model of human myocardial ischemia.
SETTING: Three university hospitals. PARTICIPANTS: The authors randomly assigned 57 patients to desflurane (volatile anesthetic) and 55 patients to propofol (intravenous anesthetic) in addition to an opiate-based anesthesia for OPCAB.
INTERVENTIONS: The 2 groups of patients received either desflurane (volatile anesthetic) or propofol in addition to an opiate-based anesthesia for OPCAB. Peak postoperative troponin I release was measured as a marker of myocardial necrosis. Prolonged hospitalization was considered as a secondary outcome.
MEASUREMENTS AND MAIN RESULTS: Patient mean age was 69 years, and 82% were men. There was a significant (p < 0.001) reduction in postoperative median (25th-75th percentiles) peak of troponin I in patients receiving volatile anesthetics, 1.2 (0.9-1.9) ng/dL, compared with patients receiving total intravenous anesthesia, 2.7 (2.1-4.0) ng/dL. This myocardial protection resulted in a reduced (p = 0.04) number (percentage) of patients requiring postoperative inotropes, 20 (35%) versus 31 (56%), and a reduced number (percentage) of patients submitted to prolonged hospitalization (> or =7 days), 7 (12%) versus 20 (36%) in the 2 groups (p = 0.005). One patient receiving total intravenous anesthesia died within 30 days of surgery.
CONCLUSIONS: Myocardial damage measured by cardiac troponin release could be reduced by volatile anesthetics during OPCAB. Because patients underwent cardiac surgery on the beating heart, these results could have implications for cardiac patients undergoing noncardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884976     DOI: 10.1053/j.jvca.2006.05.012

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  30 in total

1.  Early cardioprotective effect of sevoflurane on left ventricular performance during coronary artery bypass grafting on a beating heart: randomized controlled study.

Authors:  Ino Huseidzinović; Stjepan Barisin; Nikola Bradić; Rudolf Milanović
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

Review 2.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

3.  Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints.

Authors:  G Landoni; O Fochi; E Bignami; M G Calabrò; M C D'Arpa; E Moizo; A Mizzi; F Pappalardo; A Morelli; A Zangrillo
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2009

Review 4.  Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery.

Authors:  Radhouane Bousselmi; Mohamed Anis Lebbi; Mustapha Ferjani
Journal:  J Saudi Heart Assoc       Date:  2013-11-13

5.  Sevoflurane/propofol coadministration provides better recovery than sevoflurane in combined general/epidural anesthesia: a randomized clinical trial.

Authors:  Chao Liang; Ming Ding; Fang Du; Jing Cang; Zhanggang Xue
Journal:  J Anesth       Date:  2014-02-21       Impact factor: 2.078

6.  Comparison of the effects of desflurane and propofol anesthesia on the inflammatory response and s100β protein during coronary artery bypass grafting.

Authors:  Elif Doğan Baki; Mustafa Aldemir; Serdar Kokulu; Halit Buğra Koca; Yüksel Ela; Remziye Gül Sıvacı; Nilgün Kavrut Öztürk; Mustafa Emmiler; Fahri Adalı; Hanife Uzel
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 7.  Heat shock protein 90 inhibition and multi-target approach to maximize cardioprotection in ischaemic injury.

Authors:  Shant Der Sarkissian; Henry Aceros; Pierre-Marc Williams; Catherine Scalabrini; Mélanie Borie; Nicolas Noiseux
Journal:  Br J Pharmacol       Date:  2020-05-23       Impact factor: 8.739

8.  Does pharmacological conditioning with the volatile anaesthetic sevoflurane offer protection in liver surgery?

Authors:  Ksenija Slankamenac; Stefan Breitenstein; Beatrice Beck-Schimmer; Rolf Graf; Milo A Puhan; Pierre-Alain Clavien
Journal:  HPB (Oxford)       Date:  2012-09-25       Impact factor: 3.647

Review 9.  Protein kinase C, an elusive therapeutic target?

Authors:  Daria Mochly-Rosen; Kanad Das; Kevin V Grimes
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

10.  Troponin testing after cardiac surgery.

Authors:  J L Januzzi
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.